Variant report
Variant | nsv7932 |
---|---|
Chromosome Location | chr6:79109374-79128220 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549586087 | chr6:79109384-79109385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73762626 | chr6:79109432-79109433 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs642177 | chr6:79109445-79109446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187436266 | chr6:79109476-79109477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs180483 | chr6:79109496-79109497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550382379 | chr6:79109532-79109533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs535224367 | chr6:79109536-79109537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78111791 | chr6:79109545-79109546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs61065451 | chr6:79109546-79109547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs60424593 | chr6:79109570-79109571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142406144 | chr6:79109634-79109635 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191948569 | chr6:79109670-79109671 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs548805150 | chr6:79109671-79109672 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs236247 | chr6:79109722-79109723 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs183005788 | chr6:79109817-79109818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186592004 | chr6:79109875-79109876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs577240761 | chr6:79109910-79109911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs568173052 | chr6:79109923-79109924 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs79100560 | chr6:79109929-79109930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73762627 | chr6:79109955-79109956 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs542261596 | chr6:79109971-79109972 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534486716 | chr6:79110019-79110020 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs190206486 | chr6:79110041-79110042 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541054879 | chr6:79110051-79110052 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs182605693 | chr6:79110105-79110106 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186882589 | chr6:79110189-79110190 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144680721 | chr6:79110190-79110191 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs73762628 | chr6:79110193-79110194 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs236246 | chr6:79110265-79110266 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs548294002 | chr6:79110286-79110287 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs568210583 | chr6:79110293-79110294 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs75075878 | chr6:79110294-79110295 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs553840029 | chr6:79110299-79110300 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12204423 | chr6:79110400-79110401 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185624340 | chr6:79123604-79123605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs536878750 | chr6:79123645-79123646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs555156074 | chr6:79123754-79123755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs190480437 | chr6:79123755-79123756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528844678 | chr6:79123783-79123784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs180881779 | chr6:79123797-79123798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs12192598 | chr6:79123808-79123809 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs569245866 | chr6:79123839-79123840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577256244 | chr6:79123939-79123940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs145991940 | chr6:79123944-79123945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563269631 | chr6:79123990-79123991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs529061409 | chr6:79124012-79124013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs115544020 | chr6:79124035-79124036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184473744 | chr6:79124037-79124038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs34655350 | chr6:79124064-79124065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs112900302 | chr6:79124087-79124088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Lung cancer | 16773561 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Lung cancer | 18438408 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:79108200-79109400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr6:79109400-79110000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr6:79109600-79110200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr6:79109800-79110200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr6:79110000-79110200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr6:79110000-79110400 | Active TSS | Fetal Heart | heart |
7 | chr6:79123600-79126000 | Weak transcription | HUVEC | blood vessel |
8 | chr6:79126000-79126400 | Enhancers | HUVEC | blood vessel |